Results 141 to 150 of about 89,224 (302)

Protective Effects of Imeglimin Against Oxaliplatin‐Induced Peripheral Neurotoxicity: Evidence From In Vitro and In Vivo Studies

Journal of Applied Toxicology, EarlyView.
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura, Kano Kinjo, Keisuke Mine, Yusuke Mori, Mami Ueda, Risa Kaneko, Yuna Kamiya, Taiga Sonoda, Haruka Mimata, Shunsuke Fujita, Takehiro Kawashiri, Daisuke Kobayashi   +11 more
wiley   +1 more source

Ethylene Glycol Toxicity Presenting with Non‐Anion Gap Metabolic Acidosis [PDF]

, 2008
Sari Soghoian, Richard Sinert, Sage W. Wiener, Robert S. Hoffman   +3 more
openalex   +1 more source

Early prediction of multiple organ failure for sepsis patients based on machine learning algorithms

Journal of Intelligent Medicine, EarlyView.
Abstract In recent years, there has been a notable rise in sepsis incidence leading to more multiple organ failure and higher mortality. The lack of effective treatments for sepsis highlights the importance of early prediction in preventing multiple organ failure. This study aimed to develop a model for the early prediction of multiple organ failure in
Runnan He, Nan Su, Yuqing Wang, Yulin Sun, Xin Weng, Tania Pereira, Chenggong Hu, Keliang Xie, Meijun Pang, Kuo Zhang, Chuanxiang Huang, Xiuyun Liu   +11 more
wiley   +1 more source

Renal NHE3 is required to limit hypokalemia and metabolic acidosis during dietary potassium deficiency. [PDF]

Pflugers Arch
Nogueira Coelho J, Hayslip N, Halter RZ, Al-Masri S, Girardi ACC, Tahmasbi M, Dominguez Rieg JA, Rieg T.   +7 more
europepmc   +1 more source

Intelligent design of artificial biocatalyst for biomedical diseases

Journal of Intelligent Medicine, EarlyView.
This review summarizes recent advances in the intelligent design of artificial biocatalysts for biomedical diseases. By leveraging tailored design strategies, including environment‐responsive engineering and rational/artificial intelligence‐aided optimization, these biocatalysts enable precise modulation of pathological microenvironments and targeted ...
Lijie Zhang, Nan Song, Huanhuan Qiao, Si Sun   +3 more
wiley   +1 more source

Levetiracetam-associated high-anion gap metabolic acidosis and secondary ketogenesis: a case series. [PDF]

Clin Kidney J
Al-Baqain K, Sharawi S, Khabbaz O, Ghishan S, Ash-Shawareb Y, Kheetan M, Shweihat Y, Khitan Z.   +7 more
europepmc   +1 more source

Outcomes and adverse effects of teduglutide treatment with periodic withdrawal in pediatric short bowel patients

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives We evaluated the efficacy and safety of teduglutide in a real‐world cohort in which national reimbursement policies required treatment interruptions. The primary outcomes were reduction in parenteral support (PS) and treatment‐related adverse effects, and the secondary outcome was the impact of the mandated withdrawal periods ...
Riikka Gunnar, Annika Mutanen, Mikko P. Pakarinen, Laura Merras‐Salmio   +3 more
wiley   +1 more source

Diagnosing metabolic acidosis in the critically ill: bridging the anion gap, Stewart, and base excess methods [PDF]

, 2009
Christina W. Fidkowski, James Helstrom
openalex   +1 more source

Bicarbonate and Other Buffer Therapies in Acute Metabolic Acidosis: A Systematic Review and Meta-Analysis. [PDF]

Acta Anaesthesiol Scand
Lind PC, Hansen FG, Holmberg MJ, Jessen MK, Granfeldt A, Andersen LW.   +5 more
europepmc   +1 more source

Transcending metabolic acidosis: lactate as an epigenetic signal reprogramming diabetes-sepsis immunity. [PDF]

Front Immunol
Cai X, Han L, Liang Q.
europepmc   +1 more source